ALK-Abelló (ALK-B.CO) Financial Analysis & Valuation | Quarter Chart

ALK-Abelló (ALK-B.CO)

ALK-B.CO
Price: $37.73
Fair Value: 🔒
🔒score
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy... more
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationall... more
Description Shares
Market Cap$8.36BExchangeCPH
SectorHealthcareIndustryBiotechnology
CountryDKCEOPeter Halling
IPO Date2000-03-10CAGR0.02%
Employees2,736Websitewww.alk.net
Div. Yield0.72%Payout Ratio0.28%
Buy Back Yield—Total Yield0.72%
ALK-B.CO chart loading...
Fundamentals Technicals
Enterprise Value$42.97BP/E Ratio42.41
Forward P/E33.37PEG Ratio1.85
P/S Ratio7.57P/B Ratio7.56
P/CF Ratio22.69P/FCF Ratio26.62
EPS$0.89EPS Growth 1Y34.81%
EPS Growth 3Y282.12%EPS Growth 5Y1791.8%
Revenue Growth 1Y14.94%Gross Margin0.68%
Operating Margin0.27%Profit Margin0.2%
ROE0.2%ROA0.14%
ROCE0.22%Current Ratio3.25
Quick Ratio2.01Cash Ratio1.08
Debt/Equity0.06Interest Coverage60.48
Altman Z Score15.43Piotroski Score7

View ALK-Abelló financial charts →